Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis

Cited by (418)

Items 201–300 of 418

1. New insight on microglia activation in neurodegenerative diseases and therapeutics
   Yucong Xu, Wei Gao, Yingnan Sun, Minghua Wu · 2023 · Frontiers in Neuroscience
2. Systematic elucidation of neuron-astrocyte interaction in models of amyotrophic lateral sclerosis using multi-modal integrated bioinformatics workflow
   Vartika R. Mishra, Diane Bérangère Ré, Virginia Le Verche, Mariano J. Alvarez, Alessandro Vasciaveo, Arnaud Jacquier, Paschalis-Tomas Doulias, Todd M. Greco, Monica Nizzardo, Dimitra A. Papadimitriou et al. · 2020 · Nature Communications
3. Superoxide dismutase‐1 and other proteins in inclusions from transgenic amyotrophic lateral sclerosis model mice
   Daniel Bergemalm, Karin Forsberg, Vaibhav Srivastava, Karin S. Graffmo, Peter Munch Andersen, Thomas Brännström, Gunnar Wingsle, Stefan L. Marklund · 2010 · Journal of Neurochemistry
4. Crosstalk between astrocytes and motor neurons: What is the message?
   Ludo Van Den Bosch, Wim Robberecht · 2008 · Experimental Neurology
5. Cu/Zn-superoxide dismutase and wild-type like fALS SOD1 mutants produce cytotoxic quantities of H2O2 via cysteine-dependent redox short-circuit
   Shamchal Bakavayev, Nimrod Chetrit, Tatiana Zvagelsky, Rasha Emad Mansour, Maria Vyazmensky, Ze’ev Barak, Adrian Israelson, Stanislav Engel · 2019 · Scientific Reports
6. Astrocytic Vesicle Mobility in Health and Disease
   Maja Potokar, Nina Vardjan, Matjaž Stenovec, Mateja Gabrijel, Saša Trkov, Jernej Jorgačevski, Marko Kreft, Robert Zorec · 2013 · International Journal of Molecular Sciences
7. Salivary Biomarkers: Future Approaches for Early Diagnosis of Neurodegenerative Diseases
   Giovanni Schepici, Serena Silvestro, Oriana Trubiani, Placido Bramanti, Emanuela Mazzon · 2020 · Brain Sciences
8. Golgi fragmentation in pmn mice is due to a defective ARF1/TBCE cross-talk that coordinates COPI vesicle formation and tubulin polymerization
   Sarah Bellouze, Michael K. E. Schäfer, Dorothée Buttigieg, Gilbert Baillat, Cathérine Rabouille, Georg Haase · 2014 · Human Molecular Genetics
9. In yeast redistribution of Sod1 to the mitochondrial intermembrane space provides protection against respiration derived oxidative stress
   Christine Klöppel, Christine Michels, Julia Zimmer, Johannes M. Herrmann, Jan Riemer · 2010 · Biochemical and Biophysical Research Communications
10. Potential of activated microglia as a source of dysregulated extracellular microRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis
    Eleni Christoforidou, Greig Joilin, Majid Hafezparast · 2020 · Journal of Neuroinflammation
11. What ‘We’?
    Holly Lawford‐Smith · 2015 · Journal of Social Ontology
12. Dysfunction of Endocytic Kinase AAK1 in ALS
    Bingxing Shi, S. D. Conner, Jian Liu · 2014 · International Journal of Molecular Sciences
13. ALS Patient Stem Cells for Unveiling Disease Signatures of Motoneuron Susceptibility: Perspectives on the Deadly Mitochondria, ER Stress and Calcium Triad
    Anjoscha S. Kaus, Dhruv Sareen · 2015 · Frontiers in Cellular Neuroscience
14. T cell activation induces CuZn superoxide dismutase (SOD)-1 intracellular re-localization, production and secretion
    Giuseppe Terrazzano, Valentina Rubino, Simona Damiano, Anna Sasso, Tiziana Petrozziello, Valentina Ucci, Anna Teresa Palatucci, Angela Giovazzino, Mariarosaria Santillo, Bruna De Felice et al. · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
15. Prion-Like Propagation of Protein Aggregation and Related Therapeutic Strategies
    Sarah K. Kaufman, Marc I. Diamond · 2013 · Neurotherapeutics
16. Defining novel functions for cerebrospinal fluid in ALS pathophysiology
    Koy Chong Ng Kee Kwong, Arpan R. Mehta, Maiken Nedergaard, Siddharthan Chandran · 2020 · Acta Neuropathologica Communications
17. Evidence for Prion-Like Mechanisms in Several Neurodegenerative Diseases: Potential Implications for Immunotherapy
    Kristen Marciniuk, Ryan Taschuk, Scott Napper · 2013 · Clinical and Developmental Immunology
18. The ‘Omics’ of Amyotrophic Lateral Sclerosis
    Diana Elia Caballero-Hernández, Miguel G. Toscano, Marta Cejudo‐Guillén, Maria Luisa García‐Martín, Soledad Lopez, Jaime M. Franco, Francisco Javier Quintana, Cintia Roodveldt, David Pozo · 2015 · Trends in Molecular Medicine
19. Misfolded SOD1 and ALS: Zeroing in on mitochondria
    Sarah R. Pickles, Christine Vande Velde · 2012 · Amyotrophic Lateral Sclerosis
20. Cerebrospinal fluid concentrations of peptides derived from chromogranin B and secretogranin II are decreased in multiple sclerosis
    Niklas Mattsson, Ulla Rüetschi, Vladimir N. Podust, Mats Stridsberg, Susann Li, Oluf Andersen, Sara Haghighi, Kaj Blennow, Henrik Zetterberg · 2007 · Journal of Neurochemistry
21. A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice
    Kazunori Tanaka, Yoshinori Okada, Takuya Kanno, Asako Otomo, Yoshiko Yanagisawa, Junko Showguchi-Miyata, Etsuko Suga, Eri Kohiki, Kyuichiro Onoe, Hitoshi Osuga et al. · 2008 · Experimental Neurology
22. Transglutaminase 2 accelerates neuroinflammation in amyotrophic lateral sclerosis through interaction with misfolded superoxide dismutase 1
    Miki Oono, Ayako Okado‐Matsumoto, Akemi Shodai, Akemi Ido, Yasuyuki Ohta, Koji Abe, Takashi Ayaki, Hidefumi Ito, Ryōsuke Takahashi, Naoyuki Taniguchi et al. · 2013 · Journal of Neurochemistry
23. Derlin-1 overexpression ameliorates mutant SOD1-induced endoplasmic reticulum stress by reducing mutant SOD1 accumulation
    Akira Mori, Satoshi Yamashita, Katsuhisa Uchino, Tomohiro Suga, Tokunori Ikeda, Koutaro Takamatsu, Masatoshi Ishizaki, Tatsuya Koide, En Kimura, Shuji Mita et al. · 2010 · Neurochemistry International
24. Protein clearing pathways in ALS.
    Michela Ferrucci, Fedrica Fulceri, Luca Toti, Paola Soldani, Gabriele Siciliano, Antonio Paparelli, Francesco Fornai · 2011 · PubMed
25. Composition of Soluble Misfolded Superoxide Dismutase-1 in Murine Models of Amyotrophic Lateral Sclerosis
    Per Zetterström, Karin S. Graffmo, Peter Munch Andersen, Thomas Brännström, Stefan L. Marklund · 2012 · NeuroMolecular Medicine
26. Unraveling the Complexity of Amyotrophic Lateral Sclerosis: Recent Advances from the Transgenic Mutant SOD1 Mice
    Marco Peviani, Ilaria Caron, Chiara Pizzasegola, Francesco Gensano, Massimo Tortarolo, Caterina Bendotti · 2010 · CNS & Neurological Disorders - Drug Targets
27. Ubiquitin-Proteasome System in Neurodegenerative Disorders
    Geeta Rao Brandon Croft · 2015 · Journal of Drug Metabolism & Toxicology
28. Neuronal over‐expression of chromogranin A accelerates disease onset in a mouse model of ALS
    Samer Abou Ezzi, Roxanne Larivière, Makoto Urushitani, Jean‐Pierre Julien · 2010 · Journal of Neurochemistry
29. Gender difference in levels of Cu/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis
    Katrin Frutiger, Thomas J. Lukas, George Gorrie, Senda Ajroud‐Driss, Teepu Siddique · 2008 · Amyotrophic Lateral Sclerosis
30. Amyotrophic lateral sclerosis
    Jemeen Sreedharan, Iona Blakeney, Robert H. Brown · 2020 · Elsevier eBooks
31. Chromogranin peptides in brain diseases
    Michael Willis, Irmgard Leitner, K. A. Jellinger, Josef Marksteiner · 2011 · Journal of Neural Transmission
32. Neuroprotective Function of Cellular Prion Protein in a Mouse Model of Amyotrophic Lateral Sclerosis
    Petra Steinacker, Andreas E. Hawlik, Stefan Lehnert, Olaf Jahn, Stephen Meier, Evamaria Görz, Kerstin E. Braunstein, Marija Krzovska, Birgit Schwalenstöcker, Sarah Jesse et al. · 2010 · American Journal Of Pathology
33. Amyotrophic lateral sclerosis immunoglobulins G enhance the mobility of Lysotracker-labelled vesicles in cultured rat astrocytes
    Matjaž Stenovec, Milena M. Milosevic, Vladimir Petrušić, Maja Potokar, Zorica Stević, Mateja Prebil, Marko Kreft, Saša Trkov, Pavle R. Anđjus, Robert Zorec · 2011 · Acta Physiologica
34. Anti-superoxide dismutase antibodies are associated with survival in patients with sporadic amyotrophic lateral sclerosis
    Marka van Blitterswijk, Sunita Gulati, Elizabeth W. Smoot, Matthew Jaffa, Nancy E. Maher, Bradley T. Hyman, Adrian J. Ivinson, Clemens R. Scherzer, David Schoenfeld, Merit Cudkowicz et al. · 2011 · Amyotrophic Lateral Sclerosis
35. Propagation of the Prion Phenomenon: Beyond the Seeding Principle
    Christian Münch, Anne Bertolotti · 2012 · Journal of Molecular Biology
36. C/EBPβ expression in activated microglia in amyotrophic lateral sclerosis
    Tony Valente, Pilar Mancera, Josep M. Tusell, Joan Serratosa, Josep Saura · 2011 · Neurobiology of Aging
37. Dissociation of blood-brain barrier disruption and disease manifestation in an aquaporin-4-deficient mouse model of amyotrophic lateral sclerosis
    Saori Watanabe-Matsumoto, Yasuhiro Moriwaki, Takashi Okuda, Shinji Ohara, Koji Yamanaka, Yoichiro Abe, Masato Yasui, Hidemi Misawa · 2017 · Neuroscience Research
38. Chromogranin peptides in amyotrophic lateral sclerosis
    Anneliese Schrott‐Fischer, Mario Bitsche, Christian Humpel, Cristina L. Walcher, Hans Maier, K. A. Jellinger, Walter Rabl, Rudolf Glueckert, Josef Marksteiner · 2008 · Regulatory Peptides
39. Pathologic Potential of Astrocytic Vesicle Traffic: New Targets to Treat Neurologic Diseases?
    Nina Vardjan, Alexei Verkhratsky, Robert Zorec · 2015 · Cell Transplantation
40. Methylene blue administration fails to confer neuroprotection in two amyotrophic lateral sclerosis mouse models
    Jean‐Nicolas Audet, G. Soucy, Jean‐Pierre Julien · 2012 · Neuroscience
41. Wild-type human SOD1 overexpression does not accelerate motor neuron disease in mice expressing murine Sod1G86R
    Jean‐Nicolas Audet, Genevíève Gowing, Jean‐Pierre Julien · 2010 · Neurobiology of Disease
42. Glial Cell Lineage Expression of Mutant Ataxin-1 and Huntingtin Induces Developmental and Late-Onset Neuronal Pathologies in Drosophila Models
    Takuya Tamura, Masaki Sone, Mayumi Yamashita, Erich E. Wanker, Hitoshi Okazawa · 2009 · PLoS ONE
43. The potential roles of salivary biomarkers in neurodegenerative diseases
    Lingling Jiao, Hui-Lin Dong, Meng-Meng Liu, Peng-Lin Wu, Yi Cao, Yuan E. Zhang, Fu-Gao Gao, Huai-Yuan Zhu · 2024 · Neurobiology of Disease
44. Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotropic lateral sclerosis
    Richard Bedlack, Bryan J. Traynor, Merit Cudkowicz · 2007 · Expert Opinion on Emerging Drugs
45. Biological Spectrum of Amyotrophic Lateral Sclerosis Prions
    Magdalini Polymenidou, Don W. Cleveland · 2017 · Cold Spring Harbor Perspectives in Medicine
46. Chromogranin A in the early steps of the neurosecretory pathway
    Fanny Laguerre, Youssef Anouar, Maïté Montero‐Hadjadje · 2019 · IUBMB Life
47. Prionoids in amyotrophic lateral sclerosis
    Philippe Gosset, William Camu, Cédric Raoul, Alexandre Mezghrani · 2022 · Brain Communications
48. Evidence of calcium‐ and SNARE‐dependent release of CuZn superoxide dismutase from rat pituitary GH3 cells and synaptosomes in response to depolarization
    Mariarosaria Santillo, Agnese Secondo, Rosalba Serù, Simona Damiano, Corrado Garbi, Elena Taverna, Patrizia Rosa, Silvia Giovedı̀, Fabio Benfenati, Paolo Mondola · 2007 · Journal of Neurochemistry
49. Neurotoxic Species of Misfolded SOD1G93ARecognized by Antibodies Against the P2X4Subunit of the ATP Receptor Accumulate in Damaged Neurons of Transgenic Animal Models of Amyotrophic Lateral Sclerosis
    Sara Hernández, Anna Casanovas, Lídia Piedrafita, Olga Tarabal, Josep Enric Esquerda · 2010 · Journal of Neuropathology & Experimental Neurology
50. A seeded propagation of Cu, Zn-superoxide dismutase aggregates in amyotrophic lateral sclerosis
    Mariko Ogawa, Yoshiaki Furukawa · 2014 · Frontiers in Cellular Neuroscience
51. Accumulation and aggregate formation of mutant superoxide dismutase 1 in canine degenerative myelopathy
    Sayuri Nakamae, Yui Kobatake, R Suzuki, Toshihiro Tsukui, Shinsuke Kato, Osamu Yamato, H. Sakai, Makoto Urushitani, Sadatohi Maeda, Hiroaki Kamishina · 2015 · Neuroscience
52. Pathogenic Extracellular Vesicle (EV) Signaling in Amyotrophic Lateral Sclerosis (ALS)
    Gloria Kim, Xuan Chen, Yongjie Yang · 2022 · Neurotherapeutics
53. ALS genetic modifiers that increase survival of SOD1 mice and are suitable for therapeutic development
    Giulietta Maria Riboldi, Monica Nizzardo, Chiara Simone, Marianna Falcone, Nereo Bresolin, Giacomo P. Comi, Stefania Paola Corti · 2011 · Progress in Neurobiology
54. Elevated Expression of the Cerebrospinal Fluid Disease Markers Chromogranin A and Clusterin in Astrocytes of Multiple Sclerosis White Matter Lesions
    Marvin M. van Luijn, Marjan van Meurs, Marcel P. Stoop, Evert Verbraak, Annet F. Wierenga‐Wolf, Marie‐José Melief, Karim L. Kreft, Robert M. Verdijk, Bert A. ‘t Hart, Theo M. Luider et al. · 2015 · Journal of Neuropathology & Experimental Neurology
55. Accumulation of misfolded SOD1 outlines distinct patterns of motor neuron pathology and death during disease progression in a SOD1G93A mouse model of amyotrophic lateral sclerosis
    Sara Salvany, Anna Casanovas, Lídia Piedrafita, Sílvia Gras, Jordi Calderó, Josep Enric Esquerda · 2022 · Brain Pathology
56. Amyloid oligomers: dynamics and toxicity in the cytosol and nucleus
    Akira Kitamura, Hiroshi Kubota · 2010 · FEBS Journal
57. Amyotrophic lateral sclerosis: Protein chaperone dysfunction revealed by proteomic studies of animal models
    Mohit Raja Jain, Weiwen Ge, Stella Elkabes, Hong Li A · 2008 · PROTEOMICS - CLINICAL APPLICATIONS
58. Scavenger receptor control of chromogranin A‐induced microglial stress and neurotoxic cascades
    Claudie Hooper, Victoria A. H. Fry, Ioanna G. Sevastou, Jennifer M. Pocock · 2009 · FEBS Letters
59. From Mouse Models to Human Disease: An Approach for Amyotrophic Lateral Sclerosis
    Aziza Alrafiah · 2018 · In Vivo
60. Brain–body mechanisms contribute to sexual dimorphism in amyotrophic lateral sclerosis
    Sarah M. Jacob, Suk‐young Lee, Seung Hyun Kim, Keith A. Sharkey, Gerald Pfeffer, Minh Dang Nguyen · 2024 · Nature Reviews Neurology
61. Microglia in amyotrophic lateral sclerosis.
    Maarten Dewil, Ludo Van Den Bosch, Wim Robberecht · 2007 · PubMed
62. The curious ways of ALS
    Magdalini Polymenidou, Don W. Cleveland · 2008 · Nature
63. A Review of Biomarkers of Amyotrophic Lateral Sclerosis: A Pathophysiologic Approach
    Rawiah S. Alshehri, Ahmad R. Abuzinadah, Moafaq S. Alrawaili, Muteb Khidhran Alotaibi, Hadeel Ahmed Alsufyani, Rajaa M. Alshanketi, Aysha Abdulmalek Alshareef · 2024 · International Journal of Molecular Sciences
64. Exosomal Proteins and miRNAs as Mediators of Amyotrophic Lateral Sclerosis
    Qiao Yi Chen, Ting Wen, Peng Wu, Rui Jia, Ronghua Zhang, Jingxia Dang · 2021 · Frontiers in Cell and Developmental Biology
65. Poly(A) Tail Length of Neurohypophysial Hormones Is Shortened Under Endoplasmic Reticulum Stress
    Yoshiaki Morishita, Hiroshi Arima, Maiko Hiroi, Masayuki Hayashi, Daisuke Hagiwara, Naoya Asai, Nobuaki Ozaki, Yoshihisa Sugimura, Hiroshi Nagasaki, Akira Shiota et al. · 2011 · Endocrinology
66. Proteolytic clearance of extracellular α-synuclein as a new therapeutic approach against Parkinson disease
    Sang Myun Park, Kwang Soo Kim · 2013 · Prion
67. Amyotrophic Lateral Sclerosis
    Ericka P. Simpson, Stanley H. Appel · 2016 · Springer eBooks
68. Gibbs Energy of Superoxide Dismutase Heterodimerization Accounts for Variable Survival in Amyotrophic Lateral Sclerosis
    Yunhua Shi, Mark J. Acerson, Alireza Abdolvahabi, Richard A. Mowery, Bryan Francis Shaw · 2016 · Journal of the American Chemical Society
69. Drug Therapy in Amyotrophic Lateral Sclerosis
    B. Jane Distad, Gregg D. Meekins, Lee Loung Liou, Michael D. Weiss, Gregory T. Carter, Robert G. Miller · 2008 · Physical Medicine and Rehabilitation Clinics of North America
70. Aggregated α-Synuclein Increases SOD1 Oligomerization in a Mouse Model of Amyotrophic Lateral Sclerosis
    Yvonne Koch, Anika M. Helferich, Petra Steinacker, Patrick Oeckl, Paul Walther, Jochen Hans Weishaupt, Karin M. Danzer, Markus Otto · 2016 · American Journal Of Pathology
71. Localization of a mutant SOD1 protein in E40K-heterozygous dogs: Implications for non-cell-autonomous pathogenesis of degenerative myelopathy
    Yui Kobatake, Hiroki Sakai, Toshihiro Tsukui, Osamu Yamato, Moeko Kohyama, Jun Sasaki, Shinsuke Kato, Makoto Urushitani, Sadatoshi Maeda, Hiroaki Kamishina · 2016 · Journal of the Neurological Sciences
72. Wild-type Cu/Zn superoxide dismutase stabilizes mutant variants by heterodimerization
    Anna Weichert, Anna S. Besemer, Martina P. Liebl, Nadja Hellmann, Ingrid Koziollek‐Drechsler, Philbert Ip, Heinz Decker, Janice Robertson, Avijit Chakrabartty, Christian Behl et al. · 2013 · Neurobiology of Disease
73. Protein Misdirection Inside and Outside Motor Neurons in Amyotrophic Lateral Sclerosis (ALS): A Possible Clue for Therapeutic Strategies
    Akemi Ido, Hidenao Fukuyama, Makoto Urushitani · 2011 · International Journal of Molecular Sciences
74. Atypical Cadherin FAT3 Is a Novel Mediator for Morphological Changes of Microglia
    Tomomi Okajima, Yichen Gu, Rin-ichiro Teruya, Sarasa Yano, Takumi Taketomi, Ban Sato, Tomoki Chiba, Fuminori Tsuruta · 2020 · eNeuro
75. Human CD4+CD25+ T cells expressing a chimeric antigen receptor against aberrant superoxide dismutase 1 trigger antigen-specific immunomodulation
    David J. Graber, W. James Cook, Marie-Louise Sentman, Joana M. Murad-Mabaera, Charles L. Sentman · 2023 · Cytotherapy
76. Expression of the protein chaperone, clusterin, in spinal cord cells constitutively and following cellular stress, and upregulation by treatment with Hsp90 inhibitor
    Samantha Zinkie, Benoît J. Gentil, Sandra Minotti, Heather D. Durham · 2013 · Cell Stress and Chaperones
77. PrionsEx Vivo: What Cell Culture Models Tell Us about Infectious Proteins
    Sybille Krauß, Ina Maja Vorberg · 2013 · International Journal of Cell Biology
78. Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosis
    Yasuyuki Ohta, Genevieve Soucy, Daniel Phaneuf, Jean‐Nicolas Audet, François Gros‐Louis, Guy Armand Rouleau, Hélène Blasco, Philippe Corcia, Peter Munch Andersen, Frida Nordin et al. · 2016 · Human Molecular Genetics
79. SOD1G93A Mutant Mice Develop a Neuroinflammation-Independent Dendropathy in Excitatory Neuronal Subsets of the Olfactory Bulb and Retina
    Cornelia Ringer, Eberhard Weihe, Burkhard Schütz · 2017 · Journal of Neuropathology & Experimental Neurology
80. Imaging of glial cell morphology, SOD1 distribution and elemental composition in the brainstem and hippocampus of the ALS hSOD1G93A rat
    Stefan Stamenković, Tanja Dučić, Vera Stamenković, Alexander Kranz, Pavle R. Anđjus · 2017 · Neuroscience
81. Effects of exercise on neuroinflammation in age-related neurodegenerative disorders
    Yiping Su, Zhanguo Su · 2025 · European journal of medical research
82. Cellular distribution of chromogranin A in excitatory, inhibitory, aminergic and peptidergic neurons of the rodent central nervous system
    Martin K.-H. Schäfer, S.K. Mahata, Nikolas Stroth, Lee E. Eiden, Eberhard Weihe · 2009 · Regulatory Peptides
83. Heterogeneity in motoneuron disease
    Diether Lambrechts, Wim Robberecht, Peter Carmeliet · 2007 · Trends in Neurosciences
84. Immunodetection of Disease-Associated Conformers of Mutant Cu/Zn Superoxide Dismutase 1 Selectively Expressed in Degenerating Neurons in Amyotrophic Lateral Sclerosis
    Javier Sábado, Anna Casanovas, Sara Hernández, Lídia Piedrafita, Marta Hereu, Josep Enric Esquerda · 2013 · Journal of Neuropathology & Experimental Neurology
85. Mutant SOD1 prevents normal functional recovery through enhanced glial activation and loss of motor neuron innervation after peripheral nerve injury
    Sarah Schram, Donald Chuang, Greg Schmidt, Hristo Piponov, Cory W. Helder, James M. Kerns, Mark H. Gonzalez, Fei Song, Jeffrey A. Loeb · 2018 · Neurobiology of Disease
86. Cytotoxicity of Superoxide Dismutase 1 in Cultured Cells Is Linked to Zn2+ Chelation
    Ann‐Sofi Johansson, Monika Vestling, Per Zetterström, Lisa Lang, Lina Leinartaité, Mikael Karlström, Jens Danielsson, Stefan L. Marklund, Mikael Oliveberg · 2012 · PLoS ONE
87. Identification of Human Monoclonal Antibodies Specific for Human SOD1 Recognizing Distinct Epitopes and Forms of SOD1
    Teresa J. Broering, Hongyan Wang, Naomi K. Boatright, Yang Wang, Katherine Baptista, Gilda Shayan, Kerry A. Garrity, Can Kayatekin, Daryl A. Bosco, C. Robert Matthews et al. · 2013 · PLoS ONE
88. Cerebrospinal fluid levels of chromogranin A and phosphorylated neurofilament heavy chain are elevated in amyotrophic lateral sclerosis
    Michaela Kaiserová, Zuzana Grambalova, Pavel Otruba, David Stejskal, Hana Přikrylová Vranová, Jan Mareš, Kateřina Menšíková, Petr Kaňovský · 2017 · Acta Neurologica Scandinavica
89. Chromogranin A as a Crucial Factor in the Sorting of Peptide Hormones to Secretory Granules
    Salah Élias, Charlène Delestre, Maïté Courel, Youssef Anouar, Maïté Montero‐Hadjadje · 2010 · Cellular and Molecular Neurobiology
90. Pre-symptomatic alterations in subcellular βCGRP distribution in motor neurons precede astrogliosis in ALS mice
    Cornelia Ringer, Eberhard Weihe, Burkhard Schütz · 2009 · Neurobiology of Disease
91. Excitotoxic motoneuron disease in chick embryo evolves with autophagic neurodegeneration and deregulation of neuromuscular innervation
    Jordi Calderó, Olga Tarabal, Anna Casanovas, Dolors Ciutat, Cèlia Casas, Jerònia Lladó, Josep Enric Esquerda · 2007 · Journal of Neuroscience Research
92. Mature iPSC-derived astrocytes of an ALS/FTD patient carrying the TDP43A90V mutation display a mild reactive state and release polyP toxic to motoneurons
    Fabiola Rojas, Rodrigo Aguilar, Sandra Almeida, Elsa Fritz, Daniela Corvalán, Estíbaliz Ampuero, Sebastián Abarzúa, Polett Garcés, Armando Amaro, Iván Diaz et al. · 2023 · Frontiers in Cell and Developmental Biology
93. Specific analysis of SOD1 enzymatic activity in CSF from ALS patients with and without SOD1 mutations
    Laura Leykam, Karin Forsberg, Ulrika Nordström, Karin Hjertkvist, Agneta Öberg, Eva Jonsson, Peter Munch Andersen, Stefan L. Marklund, Per Zetterström · 2024 · Neurobiology of Disease
94. SOD1 mutations cause hypersensitivity to high-pressure-induced oxidative stress in Saccharomyces cerevisiae
    Chisako Funada, Nanami Tanino, Miina Fukaya, Yu Mikajiri, Masayoshi Nishiguchi, Masato Otake, Hiroko Nakasuji, Reika Kawahito, Fumiyoshi Abe · 2021 · Biochimica et Biophysica Acta (BBA) - General Subjects
95. The IFN-β 1b effect on Cu Zn superoxide dismutase (SOD1) in peripheral mononuclear blood cells of relapsing-remitting multiple sclerosis patients and in neuroblastoma SK-N-BE cells
    Simona Damiano, Anna Sasso, Bruna De Felice, Giuseppe Terrazzano, Vincenzo Brescia Morra, Antonio Carotenuto, Nicola Salvatore Orefice, Giuseppe Orefice, Giovanni Vacca, Annamaria Belfiore et al. · 2015 · Brain Research Bulletin
96. Multifaceted roles of extracellular vesicles in the interplay of neuroinflammation and neurodegenerative diseases
    Zhujie Deng, Haiyan Chen, Jiazhi Chen, Zhiyun Du, Wei Zhou, Zhengqiang Yuan · 2025 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
97. Insights on the Multifaceted Roles of Wild-Type and Mutated Superoxide Dismutase 1 in Amyotrophic Lateral Sclerosis Pathogenesis
    Valentina Rubino, Giuliana La Rosa, Luca Pipicelli, Flavia Carriero, Simona Damiano, Mariarosaria Santillo, Giuseppe Terrazzano, Giuseppina Ruggiero, Paolo Mondola · 2023 · Antioxidants
98. SOD1 Mutations Causing Familial Amyotrophic Lateral Sclerosis Induce Toxicity in Astrocytes: Evidence for Bystander Effects in a Continuum of Astrogliosis
    Nicole Wallis, Chew Ling Lau, Manal A. Farg, Julie D. Atkin, Philip M. Beart, Ross D. O’Shea · 2017 · Neurochemical Research
99. The P413L chromogranin B variation in French patients with sporadic amyotrophic lateral sclerosis
    Hélène Blasco, Philippe Corcia, Charlotte Veyrat‐Durebex, Cathleen Coutadeur, Clémentine Fournier, William Camu, Paul Gordon, Julien Praline, Christian Robert Andres, Patrick Vourc’h et al. · 2010 · Amyotrophic Lateral Sclerosis
100. Parkinson’s disease-associated mutations in α-synuclein and UCH-L1 inhibit the unconventional secretion of UCH-L1
     Chiho Konya, Yusuke Hatanaka, Yuuki Fujiwara, Kenko Uchida, Yoshitaka Nagai, Keiji Wada, Tomohiro Kabuta · 2011 · Neurochemistry International